European Leukemia Trial Registry
Trial: BLAST

More Details
Title Phase II Wirksamkeitsstudie zu BL-8040 bei AML
Scientific Title A double- blind, placebo controlled, randomized, multicenter, Phase II study to assess the efficacy of BL-8040 addition to consolidation therapy in AML patients
Short Title BLAST
Trialgroup OSHO/SAL
Type of Trial multicentric, randomized, double-blind, double-group
Disease Acute myeloid leukemia(AML) AML all subtypes without FAB M3
Age 18 - 75 years
Status Active
Start of Recruitment 01.01.2016
Leader Müller-Tidow, Prof. Dr. med., Carsten

Administrative needs
Kowoll, Simone
Tel: +49 (0)345 5574908

Study coordinator
Wass, Dr., Maxi
Tel: +49 (0)345 5573005

Shortprotocol Shortprotocol
created 11.10.2016 Student Studienregister
changed 18.10.2016 Student Studienregister
© ELIC European Leukemia Information Center | no responsibility is taken for correctness and completeness of this information | |